The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 541-550

  Nader, Michael A ^a   Grant, Kathleen A ^a   Davies, Huw M L ^b,c   Mach, Robert H ^a   Childers, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2BETA PROPANOYL 3BETA (4 TOLYL)TROPANE; COCAINE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG BINDING; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG POTENCY; DRUG SELF ADMINISTRATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SUBSTANCE ABUSE;

ANIMALS; COCAINE; DISCRIMINATION LEARNING; FEMALE; INJECTIONS, INTRAVENOUS; MACACA MULATTA; MALE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 0030899415     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. BENNETT, B. A., WICHEMS, C. H., HOLLINGSWORTH, C. K., DAVIES, H. M. L., THORNLEY, C., SEXTON, T. AND CHILDERS, S. R.: Novel 2-substituted cocaine analogs: Uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J. Pharmacol. Exp. Ther. 272: 1176-1186, 1995.
2. 2 antagonists. Behav. Pharmacol. 1: 355-363, 1990.
3. BLACKBURN, K. J., FRENCH, P. C. AND MERRILLS, R. J.: 5-Hydroxytryptamine uptake by rat brain in vitro. Life Sci. 6: 1653-1663, 1967.
4. BOJA, J. W., CARROLL, F. I., RAHMAN, M. A., PHILIP, A., LEWIN, A. H. AND KUHAR, M. J.: New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur. J. Pharmacol. 184: 329-332, 1990.
5. CAINE, S. B. AND KOOB, G. F.: Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816, 1993.
6. CARROLL, F. I., ABRAHAM, P., LEWIN, A. H., PARHAM, K. A., BOJA, J. W. AND KUHAR, M. J.: Isopropyl and phenyl esters of 3β-(4-substituted phenyl) tropane-2β-carboxylic acids. J. Med. Chem. 35: 2497-2500, 1992a.
7. CARROLL, F. I., GAO, Y., RAHMAN, M. A., ABRAHAM, P., PARHAM, K., LEWIN, A. H., BOJA, J. W. AND KUHAR, M. J.: Synthesis, ligand binding, QSAR, and CoMFA study of 3-β-(p-substituted phenyl) tropane-β-carboxylic acid methyl esters. J. Med. Chem. 34: 2719-2725, 1991.
8. CARROLL, F. I., GRAY, J. L., ABRAHAM, P., KUAEMKO, M. A., LEWIN, A. H., BOJA, J. W. AND KUHAR, M. J.: 3-AryI-2-(3′-substituted-1′,2′,2′-oxadiazol-5′-YL) tropane analogs of cocaine: Affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters. J. Med. Chem. 36: 2886-2890, 1993.
9. CARROLL, F. I., KUAEMKO, M. A., GAO, Y., ABRAHAM, P., LEWIN, A. H., BOJA, J. W. AND KUHAR, M. J.: Synthesis and ligand binding of 3-β-(3-substituted phenyl)- and 3β-(3,4-disubstituted phenyl) tropane-2-β-carboxylic acid methyl esters. Med. Chem. Res. 1: 382-387, 1992b.
10. CATANIA, A. C. AND REYNOLDS, G. S.: A quantitative analysis of the responding maintained by interval schedules of reinforcement. J. Exp. Analysis Behav. 11: 327-383, 1968.
11. COYLE, J. T. AND SNYDER, S. H.: Antiparkinsonian drugs: Inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166: 889-901, 1969.
12. DAVIES, H. M. L., SAIKALI, E., HUBY, N. S. J., GILLIAT, V. J., MATASHI, J., SEXTON, T. AND CHILDERS, S. R.: Synthesis of novel 2-substituted cocaine analogs and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J. Med. Chem. 37: 1262-1268, 1994.
13. DAVIES, H. M. L., SAIKALI, E., SEXTON, T. AND CHILDERS, S. R.: Novel 2-substituted cocaine analogs: Binding properties at dopamine transport sites in rat striatum. Eur. J. Pharmacol. 244: 93-97, 1993.
14. DAVIES, H. M. L., SAIKALI. E. AND YOUNG, W. B.: Synthesis of (±)-ferrugine and (±)-anhydroecognine methyl ester by a tandem cyclopropananation/Cope rearrangement. J. Org. Chem. 56: 5696-5700, 1991.
15. DIAKOGIANNIS, I. A., STEINBERG, M. AND KOSTEN, T. R.: Mazhidol treatment of cocaine abuse. A double-blind investigation. In Problems of Drug Dependence 1990: Proceeding of the 52nd Annual Scientific Meeting, ed. by L. Harris, p. 514, National Institute on Drug Abuse Research Monograph 105, US Printing House, Washington, DC, 1991.
16. GAWIN, F., RIORDAN, C. AND KLEBER, H.: Methylphenidate treatment of cocaine abusers without attention deficit disorder: A negative report. Am. J. Drug Alcoh. Abuse 11: 193-197, 1985.
17. GIROS, B., JABER, M., JONES, S. R., WIGHTMAN, R. M. AND CARON, M. G.: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612, 1996.
18. GLOWA, J. R., WOJNICKI, F. H. E., MATECKA, D., BACHER, J. D., MANSBACH, R. S., BALSTER, R. L. AND RICE, K.: Effects of dopamine reuptake inhibitors on food-and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp. Clin. Psychopharmacol. 3: 219-231, 1995a.
19. GLOWA, J. R., WOJNICKI, F. H. E., MATECKA, D., RICE, K. AND ROTHMAN, R. B.: Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparison with other drugs and repeated administrations. Exp. Clin. Psychopharmacol. 3: 232-239, 1995b.
20. HEMBY, S. E., CO, C., REBOUSSIN, D., DAVIES, H. M. L., DWORKIN, S. I. AND SMITH, J. E.: Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4-tolyl) tropane with cocaine HC1 in rats: Nucleus accumbens extracellular dopamine concentration and motor activity. J. Pharmacol. Exp. Ther. 273: 656-666, 1995.
21. JAFFE, J. H., CASCELLA, N. G., KUMOR, K. M. AND SHERER, M. A.: Cocaine-induced cocaine craving. Psychopharmacology 97: 59-64, 1989.
22. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 26: 35-44, 1984.
23. KLEVEN, M. S. AND WOOLVERTON, W. L.: Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Dep. 31: 149-158, 1993.
24. 3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251: 131-141, 1989.
25. MANSBACH, R. S. AND BALSTER, R. L.: Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Dep. 31: 183-191, 1993.
26. MELLO, N. K., BREE, M. P. AND MENDELSON, J. H.: Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J. Pharmacol. Exp. Ther. 225: 378-386, 1983.
27. NADER, M. A. AND BOWEN, C. A.: The effects of different food-reinforcement histories on cocaine self-administration by rhesus monkeys. Psychopharmacology 118: 287-294, 1995.
28. 3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology 125: 13-22, 1996.
29. NADER, M. A. AND REBOUSSIN, D. M.: The effects of behavioral history on cocaine self-administration in rhesus monkeys. Psychopharmacology 115: 53-58, 1994.
30. PORRINO, L. J., DAVIES, H. M. L. AND CHILDERS, S. R.: Behavioral and local cerebral metabolic effects of the novel tropane analog, 2β-propanoyl-3β-(4-tolyl)-tropane. J. Pharmacol. Exp. Ther. 272: 901-910, 1995.
31. PORRINO, L. J., MIGLIARESE, K., DAVIES, H. M. L., SAIKALI, E. AND CHILDERS, S. R.: Behavioral effects of the novel tropane analog, 2β-propanoyl-3β-(4-tolyl)-tropane (PTT). Life Sci. 54: PL511-PL517, 1994.
32. PRESTON, K., SULLIVAN, J. T., BERGER, P. AND BIGELOW, G. E.: Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J. Pharmacol. Exp. Ther. 267: 296, 1993.
33. RITZ, M. C. AND KUHAR, M. J.: Relationship between self-administration of amphetamine and monoamine receptors in brain: Comparison with cocaine. J. Pharmacol. Exp. Ther. 248: 1010-1017, 1989.
34. RITZ, M. C., LAMB, R. J., GOLDBERG, S. R. AND KUHAR, M. J.: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223, 1987.
35. Ross, S. B. AND RENYI, A. L.: Inhibition of the uptake of tritiated 5-hydroxy-tryptamine in brain tissues. Eur. J. Pharmacol. 7: 270-277, 1969.
36. ROTHMAN, R. B., MELE, A., REID, A. A., AKUNNE, H. C., GREIG, N., THURKAUF, A., DE COSTA, B. R., RICE, K. C. AND PERT. A.: GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40: 387-397, 1991.
37. SHERER, M. A., KUMOR, K. M. AND JAFFE, J. H.: Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 27: 117-125, 1989.
38. SKJOLDAGER, P., WINGER, G. AND WOODS, J. H.: Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Dep. 33: 31-39, 1993.
39. SPEALMAN, R. D.: Use of cocaine-discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. In Problems of Drug Dependence 1991: Proceeding of the 53rd Annual Scientific Meeting, ed. by Harris, L., pp. 175-179, National Institute on Drug Abuse Research Monograph #119, US Printing House, Washington, DC, 1992.
40. SPEALMAN, R. D., BERGMAN, J. AND MADRAS, B. K.: Self-administration of the high-affinity cocaine analog 2 β-carbomethoxy-3 β-(4-fluorophenyl)tropane. Pharmacol. Biochem. Behav. 39: 1011-1013, 1991a.
41. SPEALMAN, R. D., BERGMAN, J., MADRAS, B. K. AND MELIA, K. F.: Discriminative stimulus effects of cocaine in squirrel monkeys: Involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258: 945-953, 1991b.
42. SPEALMAN, R. D. AND KELLEHER, R. T.: Self-administration of cocaine derivatives by squirrel monkeys. J. Pharmacol. Exp. Ther. 216: 532-536, 1981.
43. TELLA, S. R.: Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol. Biochem. Behav. 51: 687-692, 1995.
44. TELLA, S. R. AND GOLDBERG, S. R.: Monoamine uptake inhibitors alter cocaine pharmacokinetics. Psychopharmacology 112: 497-502, 1993.
45. WEED, M. R., MACKEVICIUS, A. S., KEBABIAN, J. AND WOOLVERTON, W. L.: Rein- forcing and discriminative stimulus effects of β-CIT in rhesus monkeys. Pharmacol. Biochem. Behav. 51: 953-956, 1995.
46. WEED, M. R. AND WOOLVERTON, W. L.: The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275: 1367-1374, 1995.
47. WINGER, G.: Fixed-ratio and time-out changes on behavior maintained by cocaine or methohexital in rhesus monkeys: 1. Comparison of reinforcing strength. Exp. Clin. Psychopharmacol. 1: 142-153, 1993.
48. WINGER, G., SKOLDAGER, P. AND WOODS, J. H.: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J. Pharmacol. Exp. Ther. 261: 311-317, 1992.
49. WOOLVERTON, W. L.: Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol. Biochem. Behav. 26: 835-839, 1987.